Suppr超能文献

对新发抑郁发作的成年人进行心理、心理社会、药物、物理及联合治疗的系统评价和网状Meta分析。

A systematic review and network meta-analysis of psychological, psychosocial, pharmacological, physical and combined treatments for adults with a new episode of depression.

作者信息

Mavranezouli Ifigeneia, Megnin-Viggars Odette, Pedder Hugo, Welton Nicky J, Dias Sofia, Watkins Edward, Nixon Neil, Daly Caitlin H, Keeney Edna, Eadon Hilary, Caldwell Deborah M, O'Donoghue Katriona J M, Stockton Sarah, Arnold Stephanie, Thomas James, Kapur Navneet, Pilling Stephen

机构信息

Centre for Outcomes Research and Effectiveness, Research Department of Clinical, Educational & Health Psychology, University College London, London, UK.

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

出版信息

EClinicalMedicine. 2024 Aug 16;75:102780. doi: 10.1016/j.eclinm.2024.102780. eCollection 2024 Sep.

Abstract

BACKGROUND

Various effective treatments for depression exist. We aimed to identify the most effective first-line treatments for new episodes of less and more severe depression (defined by depression scale cut-off scores), to update NICE guidance on the management of Depression in Adults in England.

METHODS

Systematic review and network meta-analysis of randomised controlled trials (RCTs) published up to June 2020 (PROSPERO registration number CRD42019151328). We analysed interventions by class and individually. The primary efficacy outcome was depressive symptom change (expressed as standardised mean difference [SMD]). The review for this outcome was updated in November 2023.

FINDINGS

We included 676 RCTs, 105,477 participants and 63 treatment classes. For less severe depression, group cognitive/cognitive behavioural therapy (CT/CBT) class was efficacious versus treatment as usual [TAU], the reference treatment for this population [SMD -1.01 (95% Credible Interval [CrI] -1.76; -0.06)]. For more severe depression, efficacious classes versus pill placebo (reference treatment for this population) included combined individual CT/CBT with antidepressants [-1.18 (-2.07; -0.44)], individual behavioural therapies [-0.86 (-1.65; -0.16)], combined light therapy with antidepressants [-0.86 (-1.59; -0.12)], combined acupuncture with antidepressants [-0.78 (-1.12; -0.44)], individual CT/CBT [-0.78 (-1.42; -0.33)], mirtazapine [-0.35 (-0.48; -0.22)], serotonin and norepinephrine reuptake inhibitors [-0.32 (-0.43; -0.22)], tricyclic antidepressants [-0.29 (-0.50; -0.05)], and selective serotonin reuptake inhibitors [-0.24 (-0.32; -0.16)]. Additional treatments showed evidence of efficacy at the intervention level. Evidence for less and more severe depression was of low and low-to-moderate quality, respectively. In the 2023 update, group yoga and self-help without support emerged as efficacious for less severe depression. For more severe depression, combined group exercise with antidepressants emerged as efficacious, whereas combined light therapy with antidepressants failed to remain efficacious.

INTERPRETATION

Group CT/CBT (and possibly group yoga and self-help) appears efficacious in less severe depression, whereas antidepressants do not show evidence of effect. Combined antidepressants with individual CT/CBT, acupuncture and, possibly, group exercise, individual psychological therapies (behavioural therapies, CT/CBT) alone, and antidepressants alone appear efficacious in more severe depression. Quality of evidence, cost-effectiveness, applicability and implementation issues also need to be considered when formulating clinical practice recommendations.

FUNDING

National Institute for Health and Care Excellence.

摘要

背景

目前有多种治疗抑郁症的有效方法。我们旨在确定针对轻度和重度抑郁症新发发作(根据抑郁量表临界值定义)最有效的一线治疗方法,以更新英国国家卫生与临床优化研究所(NICE)关于成人抑郁症管理的指南。

方法

对截至2020年6月发表的随机对照试验(RCT)进行系统评价和网状Meta分析(PROSPERO注册号CRD42019151328)。我们按类别和个体对干预措施进行了分析。主要疗效结局是抑郁症状变化(以标准化均数差[SMD]表示)。该结局的综述于2023年11月更新。

结果

我们纳入了676项RCT、105477名参与者和63种治疗类别。对于轻度抑郁症,团体认知/认知行为疗法(CT/CBT)类别与常规治疗相比有效,常规治疗是该人群的对照治疗[SMD -1.01(95%可信区间[CrI] -1.76;-0.06)]。对于重度抑郁症,与片剂安慰剂(该人群的对照治疗)相比有效的类别包括个体CT/CBT与抗抑郁药联合使用[-1.18(-2.07;-0.44)]、个体行为疗法[-0.86(-1.65;-0.16)]、光疗法与抗抑郁药联合使用[-0.86(-1.59;-0.12)]、针灸与抗抑郁药联合使用[-0.78(-1.12;-0.44)]、个体CT/CBT[-0.78(-1.42;-0.33)]、米氮平[-0.35(-0.48;-0.22)]、5-羟色胺和去甲肾上腺素再摄取抑制剂[-0.32(-0.43;-0.22)]、三环类抗抑郁药[-0.29(-0.50;-0.05)]以及选择性5-羟色胺再摄取抑制剂[-0.24(-0.32;-0.16)]。其他治疗在干预水平上显示出疗效证据。轻度和重度抑郁症的证据质量分别为低质量和低至中等质量。在2023年更新中,团体瑜伽和无支持的自助疗法对轻度抑郁症有效。对于重度抑郁症,团体运动与抗抑郁药联合使用有效,而光疗法与抗抑郁药联合使用不再有效。

解读

团体CT/CBT(可能还有团体瑜伽和自助疗法)在轻度抑郁症中似乎有效,而抗抑郁药未显示出效果证据。抗抑郁药与个体CT/CBT、针灸以及可能的团体运动联合使用,单独的个体心理疗法(行为疗法、CT/CBT)以及单独的抗抑郁药在重度抑郁症中似乎有效。在制定临床实践建议时,还需要考虑证据质量、成本效益、适用性和实施问题。

资助

英国国家卫生与临床优化研究所。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b2/11377144/7526f42329f3/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验